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Abstract
The dsRNA-activated protein kinase, PKR, plays a pivotal role in the cellular antiviral response.
PKR contains an N-terminal dsRNA binding domain (dsRBD) and a C-terminal kinase domain.
An autoinhibition model has been proposed in which latent PKR exists in a closed conformation
where the substrate binding cleft of the kinase is blocked by the dsRBD. Binding to dsRNA
activates the enzyme by inducing an open conformation and enhancing dimerization. We have
tested this model by characterizing the affinity and kinetics of nucleotide substrate binding to
PKR. The fluorescent nucleotide mant-AMPPNP binds to unactivated PKR with Kd ~ 30 μM and
the affinity is not strongly affected by autophosphorylation or binding to dsRNA. Biphasic binding
kinetics are observed where the fast phase depends on nucleotide concentration but the slow phase
is ligand-independent. The kinetic data fit to a two-step model of ligand binding followed by a
slow conformation change. The kinetics are also not strongly affected by phosphorylation state or
dsRNA binding. Thus, the equilibrium and kinetic data indicate that substrate accessibility of the
kinase is not modulated by PKR activation state as predicted by the autoinhibition model. In
atomic force microscopy images, monomers of the latent protein are resolved with three separate
regions linked by flexible, bridge-like structures. Resolution of the individual domains in the
images supports a model in which unactivated PKR exists in an open conformation where the
kinase domain is accessible and capable of binding substrate.
PKR is a soluble protein kinase which is activated by dsRNA (1). PKR is constitutively
expressed in most mammalian cell types but it is induced by type 1 interferons and plays a
central role in the innate immunity defense against viral infection (2). In addition, PKR has
been implicated in a variety of cellular signal transduction pathways (3). PKR is a member
of the family of protein kinases which phosphorylate eIF2α, resulting in a blockage of
translational initiation (4). Production of dsRNA during viral infection leads to PKR
activation and inhibition of protein synthesis and apoptosis (5). PKR contains an N-terminal
double-stranded RNA binding domain (dsRBD) and a C-terminal kinase domain. The
dsRBD consists of two tandem copies of a widely distributed double stranded RNA binding
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motif (6). In an NMR structure of a PKR dsRBD construct, each of the dsRNA binding
motifs adopts the canonical αβββα fold with a ~20 amino acid intervening region that is
unstructured in the absence of dsRNA (7). The PKR kinase domain structure is typical of
eukaryotic protein kinases with a substrate binding site lying at the interface of N- and C-
terminal lobes (8).
An autoinhibition model for PKR has been proposed whereby dsRNA binding activates the
enzyme by inducing a conformational change that relieves the latent enzyme of the
inhibition that is mediated by interaction of the dsRBD with the kinase domain (9–12).
Photoaffinity labeling of PKR with ATP derivatives requires either the presence of dsRNA
(13,14) or prior autophosphorylation (14), suggesting that enzymatic activation is associated
with increased accessibility of the nucleotide binding site. Deletion of a portion of the N-
terminal region of PKR encompassing the dsRBD can produce a constitutively active kinase
capable of autophosphorylation and phosphorylation of eIF2α in the absence of dsRNA
(12,15–18). In the context of a dsRBD construct, NMR resonances associated with the
second dsRNA binding motif are broadened or disappear upon addition of exogenous kinase
domain, suggesting that it directly contacts the catalytic domain (10). Intrinsic tryptophan
fluorescence (19) and electrophoretic mobility shift assays (20) support the existence of a
dsRNA-induced conformational change.
In addition to increasing the accessibility of the active site, dsRNA binding is believed to
enhance dimerization of PKR, which in turn facilitates intermolecular autophosphorylation
(21). PKR is expressed in a latent form, but upon binding dsRNA it undergoes
autophosphorylation at multiple serine and threonine residues (22–26) as well as tyrosines
(27), producing an activated enzyme form. Following autophosphorylation, PKR is
constitutively active, and is capable of phosphorylating exogenous substrates such as eIF2α
in the absence of dsRNA (14,21,28). PKR exists in a weak monomer-dimer equilibrium with
Kd = 450 μM and dimer stability is enhanced by ~500-fold upon autophosphorylation (29).
Autophosphorylation can be induced without dsRNA by incubation of the enzyme at high
concentrations, suggesting a model where dsRNA functions to bring PKR monomers into
close proximity in a manner that is analogous to the dimerization of free PKR (29).
The activity of protein kinases is often tightly regulated. Structural studies reveal that the
conformation of the catalytic core is conserved among protein kinases in the active state;
however, the kinase domain adopts a diverse range of inactive conformations (30–32). Many
kinases, including PKR, are activated by phosphorylation within the activation loop which
may improve access of nucleotide or peptide substrates or realign critical catalytic residues.
Kinetic and equilibrium binding measurements of diverse protein kinases indicate that
activation loop phosphorylation consistently enhances the phosphoryl transfer rate by 2–4
orders of magnitude but the effects on nucleotide and peptide substrate binding affinities are
highly variable (33). In the structure of a complex of the PKR kinase domain with eIF2α,
threonine 446 in the activation loop is phosphorylated and interacts with helix αC to
correctly position catalytic residues. Phosphorylation at Thr 446 also allosterically regulates
eIF2α binding (8,34).
A quantitative molecular description of PKR activation requires correlation of functional
assays of PKR activation with direct measurement of dsRNA binding and enzymatic
dimerization. However, detailed kinetic analysis of autophosphorylation reactions is
generally difficult, and in the case of PKR the analysis is complicated by the presence of
~15 autophosphorylation sites. Thus, we have investigated PKR activation by monitoring
the affinity and kinetics of nucleotide binding to PKR in latent and activated states.
Somewhat surprisingly, we find that the affinity and kinetics are largely unaffected by
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autophosphorylation or binding to dsRNA. These data argue against models where dsRNA
binding activates PKR by opening up the substrate binding cleft.
Materials and Methods
Reagents and Materials
Wild type unphosphorylated PKR and the catalytically-inactive K296R mutant were
expressed in E. coli and purified as previously described (29). Protein concentrations were
measured by absorbance using ε280= 4.33 × 104 M−1cm−1. At enzyme concentrations
greater than 0.5 μM, PKR undergoes dsRNA – independent autophosphorylation upon
addition of ATP (29). PKR was phosphorylated by incubation in phosphorylation buffer (20
mM HEPES, 50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, pH 7.5) with 5 mM
ATP at a protein concentration of 10–15 μM. The dimeric phosphoenzyme was purified by
gel filtration on Superdex-200. We have previously demonstrated that this procedure results
in essentially complete phosphorylation of PKR (29).
All solutions were prepared using nanopure (resistivity at least 18.2 MΩ cm) water. Mant-
ATP and mant-AMPNP were purchased from Molecular Probes, mant-dATP was from Jena
Bioscience (Jena, Germany) and unlabeled nucleotides (ATP, ADP, AMPPNP) were
obtained from Sigma. Nucleotide concentrations were measured by absorption using ε255 =
2.33 × 104 M−1cm−1 for mant-nucleotides and ε259=1.54 × 104 M−1cm−1 for unlabeled
nucleotides. The complementary 40 nt RNA sequences shown below were purchased from
Dharmacon, deprotected using the manufacturer’s instructions and stored in TE buffer at
−80°C.
TS40: 5′-GGA GAA CUU CAU GCC CUU CGG AUA AGG ACU CGU AUG UAC
C-3′
BS40: 3′-CCU CUU GAA GUA CGG GAA GCC UAU UCC UGA GCA UAC AUG
G-5′
The RNA sequences were annealed in AU 200-Mg2+ buffer (20mM HEPES, 200mM NaCl,
5 mM MgCl2, 0.1mM EDTA, 0.1mM TCEP, pH 7.5) by heating to 70°C and cooling slowly
to room temperature. RNA concentrates were determined using ε260= 6.62 × 105 M−1cm−1
PKR was mixed with dsRNA at a molar ratio of 2.5 PKR: dsRNA.
Equilibrium Fluorescence Measurements
Fluorescence intensity and anisotropy data were collected with a FluoroMax-3 fluorimeter
equipped with Glan-Thompson polarizers (Jobin Yvon Inc., New Jersey). All measurements
were performed at 20°C with samples in AU 200-Mg2+ buffer using a 1 × 0.2 cm
microcuvette. Titrations were recorded with sequential additions of either enzyme or ligand
with 4 minutes between additions. Buffer blanks were subtracted from the measured
intensities and intensities were corrected for dilution. Typically, equilibrium binding of
mant-nucleotides is measured by fluorescence energy transfer from tryptophans to mant
(35,36). However, energy transfer in PKR is relatively inefficient and binding was
characterized by monitoring the fluorescence intensity or emission anisotropy increase with
direct excitation of the mant-nucleotide at 360 nm. The anisotropy is defined by
(1)
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where I|| and I⊥ are the intensities with the emission polarizers in the parallel or
perpendicular orientation with the excitation polarizer in the vertical (parallel) orientation.
The G factor corrects for polarization bias of the gratings and is given by the ratio of the
intensities (I||/I⊥) with the excitation polarizer in the perpendicular orientation. G was
determined initially for each experiment and fixed in subsequent measurements. Buffer
backgrounds were subtracted for each polarizer orientation.
Dissociation constants were measured using a fixed concentration of mant-nucleotide
titrated with PKR (forward titration) or a fixed enzyme concentration with addition of mant-
nucleotide (reverse titration). Both types of titrations were fit using a 1:1 binding model with
a single equilibrium dissociation constant, Kd. Under conditions where the enzyme and
ligand concentrations are comparable, the concentration of the enzyme-ligand complex
([EL]) is given by
(2)
where [E]0 and [L]0 are the total concentration of enzyme and ligand, respectively. Binding
isotherms were analyzed using nonlinear least-squares fitting with Igor Pro (Wavemetrics,
Lake Oswego, OR). For models where a 1:1 stoichiometry was assumed, [E]0 was fixed at
the true enzyme concentration. Alternatively, [E]0 was treated as an adjustable parameter
and the stoichiometry (N) was calculated as the ratio of [E]0 to the actual concentration of
PKR. Fluorescence intensity data were analyzed using the following equation:
(3)
where I is the fluorescence intensity (corrected for dilution), I0 is the fluorescence intensity
in the absence of PKR and ΔI is the limiting fluorescence increase due to PKR binding. The
intensity data were fit by treating I0, ΔI and Kd as adjustable parameters. For analysis of
anisotropy titrations, the measured anisotropy is the average anisotropies of the free ligand
and the ligand bound to enzyme, weighted by their concentrations and their relative
fluorescence intensities:
(4)
where rL is the anisotropy of free ligand, rEL is the anisotropy of ligand in the EL complex
and IEL/IL is the fluorescence intensity ratio. IEL/IL was separately measured for mant
nucleotide binding to each form of PKR studied. The anisotropy data were fit by treating rL,
rEL, and Kd as adjustable parameters.
Competitive anisotropy titrations were used to determine the affinities of unlabeled
nucleotides using a fixed concentration of PKR and mant-nucleotide and variable
concentration of unlabeled nucleotide. Because of the relatively weak binding of nucleotides
to PKR, it is not feasible to completely saturate the enzyme with mant-nucleotide and the
analysis of the competition titration requires solution of a cubic equation to obtain [EL]. The
competitive anisotropy titrations were analyzed using the solution described in Appendix 2
of Talavera and De la Cruz (36), constraining the total concentrations of labeled and
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unlabeled nucleotides, Kd (dissociation constant of the mant-nucleotide) and IEL/IL, while
allowing rL, rEL, KU (dissociation constant of the unlabeled nucleotide) and [E]o to float.
Stopped-Flow kinetics measurements
The kinetics of mant-nucleotide binding and dissociation were measured using an Applied
Photophysics fluorescence stopped flow instrument model SX.18MV. Mant-ATP was
employed because autophosphorylation is not a complication on the short timescale of these
measurements. All measurements were performed in AU 200-Mg2+ buffer at 20°C with
excitation at 295 nm. Emission was measured using 400 nm long-pass glass filter (Edmund
Industrial Optics, New Jersey). For measurement of association kinetics, 2 μM of enzyme
was mixed at a 1:1 ratio with variable concentrations of mant-nucleotide. Data were
collected using 1000 points over 10 s. Between 10 and 24 traces were averaged at each
nucleotide concentration and the data were fit to single and multiple exponential decay
functions using KaleidaGraph (Synergy Software). The dissociation kinetics were measured
by displacement of bound mant-nucleotide with a large excess of ATP. Enzyme (2 μM) was
pre-equilibrated with 80 μM mant-ATP and then mixed at a 1:1 ratio with 4 mM ATP. Data
were collected using 1000 points over 10 s and the resulting kinetic traces were fit to single
and multiple exponential decay functions. Kinetic simulations (37) and global data analysis
(38) were performed using KinTekSim.
Atomic force microscopy
Images were obtained with a Nanoscope III DI atomic force microscope (AFM) (Veeco,
Santa Barbara, CA) with 512 × 512 pixel resolution and a scan rate of 3 Hz, using an E type
scanner (15×15 μm2 maximum scan size). AFM tips employed were Nanosensors NCL
cantilevers with spring constants between 40 and 55 N/m and nominal resonance
frequencies of 182–199 kHz (Molecular Imaging, Phoenix, AZ, USA). All images were
plane fitted and 3rd order flattened using DI imaging software before analysis. Experiments
were carried out in 20 mM HEPES pH 7.8, 50 mM NaCl, 5mM MgCl2). Buffer solutions
were filtered prior to experiments using 0.02 μm filters (Anatop 25, Whatman, Maidstone,
UK) and heated for 10 minutes to 65°C. Protein solutions were incubated at ambient
temperature for 20 and 50 minutes. Samples were diluted to 20 nM PKR for deposition and
20 μL was then immediately applied to the surface of freshly cleaved mica and rinsed with
water after 30 seconds. The surface was blotted, dried under nitrogen, and imaged
immediately. Surface bound conformations of proteins are fixed after removal of the
surrounding buffer solution and do thus not further change during the experiment. Visual
analysis of the topography of PKR molecules and protein-dsRNA complexes was carried out
using DI imaging software (Veeco). Volume analysis of protein peaks in the AFM images
was achieved using Image SXM 169-3x software (Steve Barrett, University of Liverpool,
UK), as previously described (39,40). Between 300 and 1000 molecules of PKR from AFM
images went into the statistical analysis.
Results
Fluorescence changes of mant nucleotides upon binding to PKR
In equilibrium experiments, which employed WT PKR, the nonhydrolyzable ATP analogs
mant-AMPPNP or unlabeled AMPPNP were used to avoid complications from PKR-
catalyzed autophosphorylation reactions. In control experiments, we confirmed that both
mant-AMPPNP and AMPPNP are not substrates for PKR (data not shown). We then
examined changes in mant nucleotide fluorescence upon binding to PKR. Upon direct
excitation of the mant fluorophore at 360 nm, the fluorescence emission of mant-AMPPNP
at 440 nm increased about 1.5-fold upon addition of a large molar excess of WT
unphosphorylated PKR or to the inactive K296R mutant. This enhancement could be
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reversed by competing off the mant-labeled nucleotide with excess unlabeled AMPPNP or
ATP (results not shown). In contrast to previous reports, these data suggest that ATP is able
to bind inactive PKR. Because the mant absorption band at 360 nm strongly overlaps with
PKR tryptophan emission at 346 nm, we examined whether mant-nucleotide binding could
be detected via fluorescence resonance energy transfer. As shown in Figure 1A, mant-ATP
fluorescence emission is observed upon excitation at 295 nm and there is a ~10% intensity
increase upon addition of 1 μM PKR. The fluorescence increase is reversed by adding an
excess of ATP, indicating that the enhancement is due to resonance energy transfer from the
PKR tryptophans to the bound mant. Using the same concentrations of mant-nucleotide and
PKR, upon direct excitation of mant at 360 nm there is no increase in mant emission upon
addition of PKR (Figure 1B), confirming that the observed enhancement in Figure 1A is due
to fluorescence energy transfer. A greater extent of tryptophan→ mant energy transfer is
often observed upon binding of mant-nucleotides to ATP binding sites (e.g. references (35,
36). Although PKR contains three tryptophans within the kinase domain, two of which are
within ~ 15–20 Å of the ATP binding site, the mant moiety is perpendicular to the
tryptophan indole rings in a model of mant-ATP bound to PKR, which is unfavorable for
energy transfer (Brown, R. and Lemaire, P.A., unpublished observations). Finally, we
examined changes in mant - nucleotide emission anisotropy upon binding to PKR. Figure 2
shows that the emission anisotropy of mant-AMPPNP exhibits a large increase from ~ 0.02
to ~ 0.17 upon addition of a large excess of PKR.
Equilibrium binding of ATP to PKR
Based on the large anisotropy changes upon binding of mant-nucleotides to PKR we have
chosen to use this method for detailed characterization of equilibrium binding parameters.
Binding constants can reliably be obtained from anisotropy titrations performed using either
variable enzyme or ligand concentrations. Figure 2 shows a titration of a fixed concentration
of mant-AMPPNP with increasing concentrations of unphosphorylated, wild type PKR; we
refer to this format as a “forward titration”. In contrast to previous reports (13,14), we find
that ATP analogs bind readily to unactivated PKR. Analysis of the binding isotherm using
equation 2 yields a Kd of 33.8 ± 0.7 μM assuming a 1:1 binding stoichiometry (Table 1). If
the stoichiometry is treated as an adjustable parameter, a best-fit value of 0.95 binding sites/
PKR monomer is obtained with a similar Kd of 31.3 μM. Thus, binding of mant-AMPPNP
occurs with the expected 1:1 stoichiometry, indicating that our PKR preparations are fully
competent for nucleotide binding. In subsequent analyses, the stoichiometries were fixed at
1:1 to improve the precision of the Kd determinations.
Although PKR exists in a monomer-dimer equilibrium (29), at the maximum enzyme
concentration employed in the titration in Figure 2 only about 20% dimer is present.
However, to avoid potential complications associated with variable extents of PKR
dimerization during the course of a titration we have devised an alternative reverse
anisotropy titration where the enzyme concentration is fixed and the ligand concentration is
varied. Figure 3 shows a “reverse titration” using the same enzyme and ligand combination
employed in figure 2. The average anisotropy, <r>, decreases with increasing [mant-
AMPPNP] due to dilution of the bound ligand with excess free ligand and the shape of this
curve is determined by the dissociation constant. The reverse titration data were fit to a
simple 1:1 binding isotherm using equation 2, giving a value of Kd = 34.8 ± 3.6μM, which
closely agrees with the value obtained from the forward titration.
The reverse anisotropy titration assay was used to compare the Kd values for mant-
AMPPNP and mant-ATP binding to different PKR forms. Table 1 shows that the
dissociation constant for mant-AMPPNP binding to in vitro phosphorylated PKR is, within
error, no different from the unactivated enzyme. The Kd for a complex of unphosphorylated
PKR with an activating 40 bp dsRNA is increased about three-fold relative to the wild type
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enzyme. Thus, there appears to be no strong correlation between activation of PKR and
enhanced nucleotide binding affinity; indeed, dsRNA binding slightly weakens nucleotide
binding. Because PKR undergoes dsRNA-independent autophosphorylation at the higher
protein concentrations used in the fluorescence measurements (29) it is not possible to
directly characterize binding of mant-ATP to wild type, unphosphorylated enzyme without
complications from the catalytic reaction. Thus, we have employed a catalytically inactive
K296R mutant. In protein kinases this lysine binds the α and β phosphates of ATP and is
required for phosphoryl transfer but not ATP binding (41,42). Mant-AMPPNP binds to the
K296R mutant with a Kd of 11.5 ± 0.3 μM and a similar dissociation constant is observed
for mant-ATP. For the phosphorylated enzyme, mant-ATP binds slightly stronger than
mant-AMPPNP. Thus, the substitution of the β-γ bridging O by N does not substantially
affect ATP binding.
Competitive anisotropy titrations were performed to measure the binding affinity of
unlabeled nucleotides. Figure 4 shows that unlabeled ATP effectively competes with mant-
ATP for binding to phosphorylated PKR. Fitting the titration using the previously-measured
Kd for the labeled nucleotide gives a Kd = 24.4 ± 0.1μM for unlabeled ATP; thus, the mant
moiety does not perturb equilibrium binding of ATP to phosphorylated PKR. Similarly,
mant does not alter the affinity of AMPPNP binding to phosphorylated PKR (Table 1).
However, mant enhances the affinity of AMPPNP binding to WT, K296R and the PKR-
dsRNA complex by three-fold, and two-fold, and ~ 1.5-fold, respectively. Finally,
competition titrations were used to assess binding of the reaction product ADP. ADP binds
about twofold more strongly than ATP to the phosphorylated and K296R enzymes and about
two-fold more strongly than AMPPNP to the PKR-dsRNA complex. However, the affinity
of ADP and AMPPNP are approximately equal for unphosphorylated PKR.
Kinetics of nucleotide binding to PKR
We have characterized the kinetics of nucleotide binding to PKR by stopped-flow
fluorescence measurements to define the binding mechanism and to determine whether the
association or dissociation rates are sensitive to the enzyme activation state. Under pseudo
first-order conditions where the ligand is in excess, the most sensitive kinetic measurements
are obtained by monitoring mant emission stimulated by tryptophan →mant energy transfer.
Figure 5A shows that binding of 50 μM mant-ATP to unphosphorylated PKR gives rise to a
large rapid fluorescence increase complete within 20 ms along with a slow, low amplitude
increase. The data fit well to a two exponential model with kobs, 1= 514 ± 9 s−1 (96%
amplitude) and kobs,2 of 39 ± 9 s−1 (4% amplitude). The fluorescence amplitude of the
kinetic transient extrapolated to t=0 corresponds to the fluorescence of the free ligand,
indicating that there are no undetected fast phases within the instrument dead time (data not
shown).
Figure 5B shows that the rate of the fast phase increases linearly with ligand concentration
but the rate of the slow phase is essentially concentration-independent. The slope and
intercept values for kobs,1 and the average value of kobs,2 are displayed in table 2. The
relative amplitudes of the two phases are dependent on mant-ATP concentration: the
contribution of kobs,1 ranges from 87% at 5 μM to 96% at 50 μM ligand (see Table S1).
Because preparations of mant-ATP contain a mixture of 2′- and 3′-isomers, we also
examined the binding kinetics of a single isomer nucleotide, 3′-mant-2′deoxy ATP. As with
mant-ATP, 3′-mant-2′deoxy ATP binds to both WT and K296R PKR with biphasic
association kinetics, indicating that this reaction pattern is not due to ligand heterogeneity
(data not shown).
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Binding of mant-ATP to other PKR forms also gives rise to a biexponential fluorescence
increase with a concentration-dependent fast phase and a concentration-independent slow
phase. Table 2 compare the kinetic parameters. Overall, the binding kinetics are not strongly
affected by phosphorylation, binding to dsRNA or the K296R mutation. The largest change
occurs for K296R where the value of kobs,1 :intercept is decreased about two-fold relative to
unphosphorylated PKR. Also, in all cases the relative amplitude of the fast phase increases
with increasing ligand concentration (see Table S1). For the phosphorylated and dsRNA-
bound forms, the relative amplitudes are similar to the unphosphorylated enzyme; however,
for the K296R mutant the fraction of the fast phase varies more strongly, increasing from
44% to 91% between 10 and 50 μM mant-AMPPNP.
The dissociation kinetics for mant-ATP were directly measured by trapping experiments
where the PKR-mant-ATP complex was mixed with a large molar excess of unlabeled ATP.
Figure 6 shows that the dissociation of mant-ATP from unphosphorylated PKR occurs with
a dominant fast phase with kobs,1 of 175 ± 2 s−1 (94% amplitude) and a slow, low amplitude
phase with kobs,2 of 43.1 ± 5.5 s−1. Biphasic dissociation kinetics were observed by the other
PKR forms (table 2). As in the case of the association kinetics the observed rate constants
for dissociation are fairly similar for the different PKR forms. The most notable effect is a
decrease in both kobs,1 and kobs,2 for the K296R mutant. More dramatic changes are
observed in the relative amplitudes of the two phases: for phosphorylated PKR the fast
phase decreases to 49% and for the K296R mutant it drops to 13%.
The presence of two rate constants for the binding of mant-ATP indicates a minimal two
step kinetic mechanism involving bimolecular association and isomerization reactions. In
scheme 1, the nucleotide first binds to PKR to form EL, which then undergoes a
conformational change to E′L.
Alternatively, the free enzyme may undergo a conformational change (E →E′) prior to
binding nucleotide (Scheme 2).
Although these two mechanisms cannot be distinguished based solely on the measured rate
constants (43), only scheme 1 is fully consistent with the kinetic data. In Scheme 2, E′L is
the only species that gives rise to fluorescence energy transfer and in the dissociation
experiments its decay would be monoexponential with a rate constant of k−2. However, a
biexponential fluorescence decrease is observed experimentally (Figure 6). In contrast,
Scheme 1 predicts biexponential decay kinetics for the dissociation experiment. For the
association reaction, both schemes predict that formation of E′L proceeds with a lag phase
associated with population of an intermediate (either EL or E′). However no lag phase is
observed and both kinetic phases of the association reaction have positive amplitude,
indicating that scheme 2 is incorrect. Scheme 1 is consistent with the data provided that both
EL and E′L contribute to the fluorescence increase, giving rise to an overall fluorescence
change with two positive kinetic phases.
For scheme 1, the values of fast and slow phases can be expressed in terms of the
elementary rate constants using the square root approximation (43) to give
(5)
(6)
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Thus, as observed in Figure 5B, kobs,1 should exhibit a linear substrate concentration
dependence, where the slope is given by k1 and the intercept by k−1+k2+k−2. Although
kobs,2 is predicted to show a hyperbolic concentration dependence, this dependence may not
be apparent in systems where k2 and k−2 are small compared to k1[S] and k−1. In the limit of
a single step mechanism, where the isomerization reaction is not present, k2= k−2= 0 and
only a single exponential phase is expected with kobs= k1[S] + k−1. For the
unphosphorylated enzyme, if we neglect the slow kinetic phase and calculate Kd = k−1/k1
based on the intercept and slope of kobs,1 we obtain a value Kd= 33.0 μM, which agrees well
with the equilibrium values of Kd =34–35 μM for mant-AMPPNP (Table 1). This agreement
presumably is associated with the small contribution of the slow phase and low population
of the E′L state for this enzyme form.
Figure 7 shows a global fit of the wild type PKR binding kinetics to scheme 1 over the range
of 5 - 30 μM mant-ATP, making the simplifying assumption that EL and E′L contribute
equally to the observed fluorescence change. The good fit provides further support for
scheme 1 and gives best values of k1=7.33 ± 0.07 μM−1s−1, k−1 = 137± 2 s−1, k2 =1.8± 0.7
s−1 and k−2 =13.0 ± 10.7 s−1. The parameters obtained from the global analysis are
reasonably consistent with the value of k1 obtained from the linear substrate concentration
dependence of kobs,1 and with the trapping experiments, where the fast phase is equal to k−1
and the slow phase corresponds to k−2. Although the standard errors for k2 and k−2 are
large, it is clear that ligand binding and dissociation are significantly faster than the
subsequent isomerization reaction.
Atomic force microscopy
In AFM images of latent PKR (Figure 8A), we observe molecules with clearly resolved
features. Based on volume analysis of the individual particles, we identify the molecules as
monomers of the protein (data not shown). A large number of proteins have been imaged
using AFM in air on mica surfaces (40, 44–49). In these images, proteins generally appear
globular with little or no disordered regions, although multiple domains and multiple
subunits have been resolved in a few cases [D.A. Erie, unpublished data; (45, 50)]. The
degree of structure apparent in the images of the PKR monomers is striking for a small (62
kDa) protein.
The AFM images the PKR monomers reveal up to three distinguishable structured regions
linked by bridge-like stretches. In some cases, the linker regions are structured (for example
Figure 8B-4); however, this structured conformation appears unstable because in most
molecules the linker adopts an unfolded, extended form. We have classified the different
observed conformations into four groups, as shown in Figure 8B. Some molecules feature a
compact arrangement (Figure 8B-4), while others appear almost completely extended
(Figure 8B-1). Statistical analysis of the different conformations shows that the four shape
categories are represented with approximately equal frequencies in the images (data not
shown), which is consistent with a high linker flexibility.
Addition of ATP had no effect on the molecular conformations of PKR seen in AFM (data
not shown). Because these experiments were carried out at low protein concentrations, PKR
did not undergo dsRNA-autophosphorylation during AFM analysis (29). Phosphorylated
PKR (Figure 8C) exhibited volumes consistent with PKR monomers and dimers (and higher
oligomeric states) in agreement with previous studies finding enhanced dimerization of
phosphorylated PKR (29). Although the phosphorylated protein frequently showed globular,
condensed shapes, many of the molecules still displayed open extended shapes similar to
those seen for unphosphorylated PKR, suggesting that the kinase domain is accessible to
substrate in both the unphosphorylated and the phosphorylated protein.
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A key finding from our equilibrium and kinetic studies of nucleotide binding to PKR is that
ATP is capable of binding to unphosphorylated enzyme and the dissociation constants and
kinetics are largely unaffected by phosphorylation or binding to dsRNA. Although slight
changes in PKR affinity and binding kinetics are observed, these differences are not likely to
be physiologically significant, since the millimolar intracellular concentration of ATP is
about two orders of magnitude higher than the average Kd. These results contrast with
earlier studies indicating that photocrosslinking of either ATP or 8-azido ATP to PKR
requires dsRNA (13,14) or prior autophosphorylation (14). The origin of these discrepancies
is not clear but may relate to differences in methodology or sample preparation. In
particular, the current measurements were performed using direct fluorescence binding
methods with purified enzyme. Control experiments demonstrate that the mant fluorophore
does not strongly perturb the affinity or kinetics.
Based on the nucleotide binding data, we cannot exclude the possibility that dsRNA binding
or phosphorylation alter accessibility of the peptide substrate binding region. No correlation
between substrate recognition and dsRNA binding has been described. However, it has been
reported that eIF2α binding to a PKR kinase domain construct requires phosphorylation at
threonine 446 within the activation loop whereas Km for the nonspecific substrate histone
H2A is unaffected by PKR phosphorylation (34). In contrast, earlier studies using full length
PKR demonstrated that eIF2α can bind to unphosphorylated PKR (51). Although the
activities of many eukaryotic protein kinases are enhanced by phosphorylation events within
the activation loop, in most cases, peptide substrate or nucleotide binding are not controlled
by phosphorylation; instead, the dominant effect is to enhance the phosphoryl transfer rate
(33,52). Further studies are required to determine whether PKR follows this dominant
paradigm.
Although mutation of lysine 296 renders PKR completely inactive (53), the K296R mutant
is capable of binding adenosine nucleotides. This lysine is conserved in most kinases where
it interacts with the α and β phosphates of ATP. Mutants of this lysine in other kinases,
including lck (42), erk2 (41) and PKA (54), are also capable of binding ATP but are
catalytically impaired. In PKR, the K296R mutation decreases adenosine nucleotide Kd
values by 3–6 fold but, in erk2 the analogous lysine → arginine mutation slightly increases
the Km for ATP, suggesting that the lysine – ATP interaction does not contribute strongly to
the overall binding affinity.
The observation of biphasic kinetics in the stopped-flow measurements of ATP binding to
PKR supports a minimal two-step model involving bimolecular association and
isomerization steps. In general, these steps can occur in either order; however, only scheme
1, where binding precedes the isomerization reaction, is consistent with the biphasic
fluorescence decrease observed in dissociation experiments and the presence of two positive
phases in the association measurements. Furthermore, kinetic transients obtained at multiple
ligand concentrations can be globally fit to scheme 1. Qualitatively similar kinetics are
observed in all PKR forms, indicating that the overall reaction mechanism is not altered by
phosphorylation, dsRNA binding or the K296R mutation. Transient kinetic measurement
have led to a similar kinetic model for nucleotide binding to protein kinase A involving
ligand binding and subsequent isomerization; however, an additional kinetic phase was
observed and assigned to an additional isomerization step (35). Based on kinetic data alone
the isomerization step cannot be definitively assigned to a specific conformational change or
to a step in the catalytic cycle. The ATP bound form of the PKR kinase domain has a
slightly more open conformation of the two lobes of the catalytic core than the unliganded
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kinase (8), suggesting that PKR undergoes a conformational change upon nucleotide
binding. The slow isomerization may be associated with this conformational change.
The AFM images of latent PKR reveal monomeric molecules that are extended and
segmented. These highly asymmetric structures are fully consistent with the previously
reported high frictional ratio f/f0 of 1.62 (29) and the large radius of gyration for PKR (19).
Structured domains are resolved in the AFM images and are linked by flexible, bridge-like
regions. Resolution of this domain structure indicates that latent PKR exists in an open
conformation consistent with unhindered binding of ATP to the kinase domain. The range of
different PKR conformations observed on a surface using AFM indicates that highly flexible
regions link the individual segments, allowing these domains to land on the surface in
different orientations and at different distances from each other. In some cases, the linker
regions appear to be structured; however, this structured conformation is very unstable since
the majority of these regions adopt an unfolded, extended conformation. The high flexibility
of these regions is consistent with NMR evidence that the 20 amino acid linker between the
dsRBMs is unstructured in solution (7). The conformation of the ~ 100 residue segment
lying between the dsRBD and kinase domain is unknown but may contain additional flexible
regions. Although globular, condensed shapes are frequently observed in the AFM images
of phosphorylated PKR, many molecules exhibit domain structure. Thus, phosphorylated
PKR can adopt an open shape similar to the latent enzyme, consistent with an insignificant
effect of the protein phosphorylation state on ATP binding affinity.
The present nucleotide binding and AFM data do not support the autoinhibition model for
PKR activation and indicate an open conformation for the resting enzyme. Equilibrium and
kinetic measurements of nucleotide binding demonstrate that the ATP binding site is fully
accessible in the unphosphorylated enzyme in the absence of dsRNA. AFM data indicate
that the dsRBD is not stably associated with the kinase domain. PKR can be activated by
dimerization at high protein concentrations in the absence of dsRNA (29), arguing against a
specific involvement of the dsRNA binding domains in enzymatic activation. In addition,
fusion of a heterologous dimerization domain with the PKR catalytic domain enhances
autophosphorylation and eIF2α kinase function in vivo, suggesting that dimerization is
sufficient to induce activation in the absence of exogenous activator (9). Heparin, a known
activator, is capable of activating PKR deletion mutants lacking the dsRNA binding domain
(55,56), providing further evidence that the dsRNA binding domain is not directly
associated with enzymatic activity. Thus, PKR activation by dsRNA and heparin may
simply be associated with increasing the local enzyme concentration and enhancing
functional dimerization by binding PKR to a polymeric substrate containing multiple
binding sites.
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Fluorescence spectra of mant-ATP in the absence and presence of wild-type PKR. A: mant-
ATP (—), PKR (.....), mant-ATP + PKR ( , blue) and mant-ATP +PKR + unlabeled ATP
( , red). Spectra were recorded at an excitation wavelength of 295 nm with excitation and
emission bandwidths of 2 nm. B: Spectra of mant-ATP (—), and mant-ATP + PKR ( ,
red). Spectra were recorded at excitation wavelength of 360 nm with excitation and emission
bandwidths of 2 nm. Concentrations: mant-ATP, 122 μM; PKR, 1 μM; ATP, 2 mM.
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Binding of mant-AMPPNP to PKR measured by forward anisotropy titration. The
fluorescence anisotropy of 20 μM mant-AMPPNP was measured at increasing
concentrations of PKR at an excitation wavelength of 360 nm and emission wavelength of
443 nm with spectral bandwiths of 2 nm and 4 nm for excitation and emission respectively.
Fluorescence intensity at each polarizer orientation were integrated for 1 s and
measurements were averaged until the maximum standard deviation drops below 0.1%.
Each data point represents the average of 3–4 measurements. The solid line represents a fit
of the data to a 1:1 binding model to obtain Kd = 33.8± 0.7μM, rL = 0.0213± 0.0003 and rEL
= 0.1914± 0.0010.
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Binding of mant-AMPPNP to PKR measured by reverse fluorescence anisotropy. mant-
AMPPNP was titrated against 40 μM PKR and the fluorescence anisotropy was measured at
an excitation wavelength of 360 nm and emission wavelength of 443 nm with spectral
bandwiths of 2 nm and 4 nm for excitation and emission respectively. Fluorescence intensity
at each polarizer orientation were integrated for 1 s and measurements were averaged until
the maximum standard deviation drops below 0.1%. Each data point represents the average
of 3–4 measurements. The solid line represents a fit of the data to a 1:1 binding model to
obtain Kd = 34.8± 3.6 μM, rL = 0.0407± 0.0016 and rEL = 0.2356 ± 0.0096.
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Binding of ATP to phosphorylated PKR measured by competition fluorescence anisotropy.
In this case, ATP was titrated against 39.5 μM of phosphorylated PKR (measured by UV
absorption at 280 nm) with 11.3 μM mant-ATP and the fluorescence anisotropy measured
with excitation and emission at 360 and 443 nm respectively. Each data point represents and
average of 3–4 repeated measurements at the same ATP concentration. The Kd of mant-ATP
binding to phosphorylated PKR measured by reverse anisotropy titration and used in the
fitting function was 24.6 μM.
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Kinetics of mant-ATP binding to unphosphorylated wild-type PKR measured by stopped-
flow fluorescence spectroscopy. A: Time-dependent changes in fluorescence of 50 μM
mant-ATP in the presence of 1 μM unphosphorylated PKR. The mixture was excited at 295
nm and fluorescence emission above 400 nm measured using a cutoff filter. The plot
represents average of 12 runs with each run made of 1000 data points taken over 10 s in a
log time interval. The solid line is the two exponential fits to the data. The first phase
contributed 96% to the total amplitude with the observed rate constant (kobs,1) of 514 ± 9 s−1
while the second phase contributed 4% to the total amplitude with kobs,2 of 39 ± 9 s−1. B:
The effect of mant-ATP concentration on kobs. The solid line is a linear fit to the data from
two experiments. kobs,1 (●) increases linearly as the concentration of mant-ATP and a least
squares fit yields kobs,1:slope = 6.25 ± 0.35 μM−1·s−1 and kobs,1:intercept = 206 ± 11
s−1·kobs,2 (□) is essentially independent of mant-ATP concentration with an average value of
48.9 ± 9.9 s−1.
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Kinetics of mant-ATP dissociation from unphosphorylated wild-type PKR measured by
stopped-flow fluorescence spectroscopy. Time-dependent changes in fluorescence of 40 μM
mant-ATP in the presence of 1 μM unphosphorylated PKR competed off with 2 mM ATP.
The mixture was excited at 295 nm and fluorescence emission above 400 nm measured
using a cutoff filter. The plot represents average of 21 runs with each run made of 1000 data
points taken over 10 s in a log time interval. The solid line is the two exponential fits to the
data. The first phase contributed 94% to the total amplitude with rate constant (kobs,1) of 175
± 2 s−1 while the second phase contributed 6% to the total amplitude with kobs,2 of 43.1 ±
5.5 s−1.
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Simulation of the kinetics of mant-ATP binding to unphosphorylated PKR: [EL] (– –), [E′L]
× 8 (.....), [EL] + [E′L] (—). The kinetics were simulated based on a global fit of the
experimental data to scheme 1 over the range of 5 – 30 μM mant-ATP, assuming that that
EL and E′L contribute equally. The adjustable parameters are the four rate constants and an
overall scaling factor, giving best fit values of k1=7.33 ± 0.07 μM−1s−1, k−1 = 137± 2 s−1,
k2 =1.8± 0.7 s−1 and k−2 =13.0 ± 10.7 s−1.
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AFM images of (A) unphosphorylated PKR and (C) phosphorylated PKR. Images are 1 μm
× 1 μm with a height scale of 2 nm. In (A), different molecular conformations can be found.
Examples of these are shown enlarged in (B): almost entirely extended conformation (1),
shapes with three resolvable segments (2), shapes showing only two resolved segments and
a broader linking region (3), and molecules in which the individual segments are very close
together (4). The scale bar in (B1) is 20 nm. Height scale of all images is 2 nm as indicated
next to image (C).
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Table 1
Equilibrium dissociation constants for interaction of nucleotides with PKR.a
Nucleotide Enzyme Form
Unphosphorylated Phosphorylated K296R Mutant Unphos. + 40mer dsRNA
mant-AMPPNP 33.8 ± 0.7
b
34.8 ± 3.6c
34.0 ± 0.7b 11.5 ± 0.3b 102.3 ± 3.6c
mant-ATP - 24.6 ± 1.7c 10.3 ± 0.8b -
ATP - 24.4 ± 0.1d 20.2 ± 1.7d -
AMPPNP 97.7 ± 1.7d 34.0 ± 0.1d 22.8 ± 2.0d 160.5 ± 1.4d
ADP 76.5 ± 1.1d 11.6 ± 0.7d 12.5 ± 0.3d 67.0 ± 0.7d
a






Competition titration using mant-AMPPNP.
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